TrueBlue (NYSE:TBI – Get Free Report) issued its quarterly earnings results on Wednesday. The business services provider reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.14, Zacks reports. TrueBlue had a negative net margin of 6.97% and a negative return on equity of 2.69%. The business had revenue of $385.95 million for the quarter, compared to analyst estimates of $385.04 million. TrueBlue updated its Q1 2025 guidance to EPS.
TrueBlue Stock Performance
TBI stock traded down $0.60 during mid-day trading on Thursday, reaching $6.85. The company had a trading volume of 98,965 shares, compared to its average volume of 118,487. TrueBlue has a fifty-two week low of $6.63 and a fifty-two week high of $12.88. The company has a market capitalization of $202.49 million, a price-to-earnings ratio of -1.79, a price-to-earnings-growth ratio of 3.51 and a beta of 1.42. The firm has a fifty day simple moving average of $7.92 and a 200 day simple moving average of $7.77.
Wall Street Analyst Weigh In
TBI has been the subject of a number of analyst reports. BMO Capital Markets decreased their price objective on shares of TrueBlue from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded TrueBlue from a “sell” rating to a “hold” rating in a research report on Friday, February 14th.
About TrueBlue
TrueBlue, Inc, together with its subsidiaries, provides specialized workforce solutions in the United States, Canada, the United Kingdom, Australia, and Puerto Rico. It operates through three segments: PeopleReady, PeopleManagement, and PeopleScout. The company PeopleReady segment provides general, industrial, and skilled trade contingent staffing services for construction, transportation, manufacturing, retail, hospitality, and renewable energy industries.
Read More
- Five stocks we like better than TrueBlue
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Tesla: 2 Reasons to Buy, 1 Reason to Run
- What is the Nasdaq? Complete Overview with History
- Should You Hold Nvidia Stock for the Long Haul or Trade It?
- Insider Trades May Not Tell You What You Think
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Receive News & Ratings for TrueBlue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue and related companies with MarketBeat.com's FREE daily email newsletter.